Google
PSTV — PLUS THERAPEUTICS INC (Healthcare >> Biotechnology)
PSTV FAQ
What is PSTV's P/E ratio?
PLUS THERAPEUTICS INC (PSTV) currently trades at a P/E ratio of 7.68.
What is PSTV's ROE?
PLUS THERAPEUTICS INC reports a Return on Equity (ROE) of -99.75%.
What is PSTV's dividend yield?
PLUS THERAPEUTICS INC offers a dividend yield of 0.00%.
What is PSTV's Deepscope Quality Score?
Deepscope rates PSTV's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy PSTV?
Deepscope's AI Timing Score for PSTV is 69 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does PSTV belong to?
PLUS THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 5.41
Price
-0.34
(-5.83%)
Day Change
|
|
|---|
PSTV, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 89 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.41 |
| PBV / Sector |
3.31 / 4.63
|
| Earning Per Share | -1.63 |
| PE / Sector |
7.68 / 17.43
GREAT
|
| PEG or PE/Growth / Sector |
-0.09 / 0.53
|
| Average 1M Daily Value |
0.88 M
GREAT
|
| Average 1W Daily Value |
0.60 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
47% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:09:07 |
| Symbol | PSTV |
| Name | PLUS THERAPEUTICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 6.88 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 39.55 / 8,857.28 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 6420 LEVIT GREEN BOULEVARD, Houston, TX, United States, 77021
Phone: 737 255 7194
Website: https://plustherapeutics.com
Sector: Healthcare >> Biotechnology
Description: Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary liver cancers by intra-arterial injection. In addition, it develops and commercializes laboratory-developed tests comprising the CNSide Test to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Houston, Texas.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
